Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Faron Pharmaceuticals (FARN)

Price 150.00p on 15-11-2024 at 17:30:01
Change -2.50p -1.64%
Buy 155.00p
Sell 145.00p
Buy / Sell FARN Shares
Last Trade: Sell 265.00 at 146.00p
Day's Volume: 8,646
Last Close: 150.00p
Open: 152.50p
ISIN: FI4000153309
Day's Range 150.00p - 152.50p
52wk Range: 89.00p - 360.00p
Market Capitalisation: £157m
VWAP: 150.16011p
Shares in Issue: 105m

Recent Trades History Faron Pharmaceuticals (FARN)

Buy/Sell Volume Trade Prc Trade Type Trade Time
Sell* 265 146.00p Ordinary
15:21:53 - 15-Nov-24
Buy* 200 151.00p Ordinary
13:06:58 - 15-Nov-24
Buy* 100 151.00p Ordinary
12:45:26 - 15-Nov-24
Buy* 885 151.00p Ordinary
12:43:25 - 15-Nov-24
Sell* 500 151.00p Ordinary
11:39:44 - 15-Nov-24
Sell* 2,409 150.00p Ordinary
11:06:10 - 15-Nov-24
Sell* 3,100 150.00p Ordinary
08:16:15 - 15-Nov-24
Sell* 1,000 150.03p Ordinary
08:10:33 - 15-Nov-24
Buy* 187 153.90p Ordinary
08:03:30 - 15-Nov-24

Share Price History for Faron Pharmaceuticals

Time period:
to
Date Open High Low Close Volume

Share News for Faron Pharmaceuticals

Faron Pharma shares surge as US FDA grants fast track designation

27th Aug 2024 11:08

(Alliance News) - Faron Pharmaceuticals Ltd on Tuesday said its loss widened in the first half of 2024, as the company successfully advanced the development of its flagship bexmarilimab treatment. Read More

UK earnings, trading statements calendar - next 7 days

20th Aug 2024 14:21

Read More

IN BRIEF: Faron Pharmaceuticals joins US grant for battlefield wounds

13th Aug 2024 13:23

Faron Pharmaceuticals Ltd - Turku, Finland-based clinical-stage biopharmaceutical maker - Joins consortium that has received a USD1.5 million grant from the US Department of Defense to create preservation strategies for multiple tissue types, including skin, bone, nerves and blood vessels. Tissue preservation is essential for successful transplants, due to time lags in receiving donor tissue. Faron and another industry partner, BMIOrganbank, will work with researchers at two academic centres, Duquesne University's School of Pharmacy in Pittsburg, Pennsylvania and Atrium Health Wake Forest Baptist Medical Center in Winston-Salem, North Carolina. Faron says the grant specifically will be used to investigate the use of intravenous interferon beta for the prevention of ischemia-reperfusion injury in battlefield victims when using a lifesaving tourniquet for the prevention of excessive blood loss. Read More

EXECUTIVE CHANGES: New chief executives at Cornish Metals and ValiRx

12th Aug 2024 12:01

(Alliance News) - The following is a round-up of London-listed company director and manager changes announced in August so far and not separately reported by Alliance News: Read More

IN BRIEF: Faron Pharmaceuticals names Petri Bono as CMO

6th Aug 2024 16:51

Faron Pharmaceuticals Oy - Turku, Finland-based clinical-stage biopharmaceutical company - Names Petri Bono as the new chief medical officer with effect from August 15. Bono has served as CMO of Terveystalo, the largest private healthcare service provider in Finland. Read More

FTSE 100 Latest
Value8,063.61
Change-7.58

Login to your account

Forgot Password?

Not Registered